Dean Tozer Acquires 48,000 Shares of Cytomedix Stock (CMXI)
Cytomedix (NASDAQ:CMXI) Insider Dean Tozer purchased 48,000 shares of Cytomedix stock on the open market in a transaction dated Wednesday, August 20th. The stock was purchased at an average price of $0.39 per share, with a total value of $18,720.00. Following the completion of the purchase, the insider now directly owns 48,000 shares in the company, valued at approximately $18,720. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Cytomedix (NASDAQ:CMXI) remained flat at $0.40 during during mid-day trading trading on Thursday. 60,694 shares of the company’s stock traded hands. Cytomedix has a 52 week low of $0.33 and a 52 week high of $0.68. The stock’s 50-day moving average is $0.39 and its 200-day moving average is $0.47. The company’s market cap is $49.8 million.
Cytomedix, Inc is a United States-based company that develops biologically active regenerative therapies for wound and tissue repair.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.